IL159085A0 - Heterocyclic derivatives and pharmaceutical compositions containing the same - Google Patents
Heterocyclic derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL159085A0 IL159085A0 IL15908502A IL15908502A IL159085A0 IL 159085 A0 IL159085 A0 IL 159085A0 IL 15908502 A IL15908502 A IL 15908502A IL 15908502 A IL15908502 A IL 15908502A IL 159085 A0 IL159085 A0 IL 159085A0
- Authority
- IL
- Israel
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- heterocyclic derivatives
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001161489 | 2001-05-29 | ||
| PCT/JP2002/005097 WO2002096880A1 (fr) | 2001-05-29 | 2002-05-27 | Nouveau compose heterocyclique et son utilisation medicinale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL159085A0 true IL159085A0 (en) | 2004-05-12 |
Family
ID=19004756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15908502A IL159085A0 (en) | 2001-05-29 | 2002-05-27 | Heterocyclic derivatives and pharmaceutical compositions containing the same |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7557123B2 (fr) |
| EP (1) | EP1403253A4 (fr) |
| JP (1) | JP4279136B2 (fr) |
| KR (2) | KR20040030647A (fr) |
| CN (1) | CN1242994C (fr) |
| AR (1) | AR036036A1 (fr) |
| AU (1) | AU2002308889B2 (fr) |
| BR (1) | BR0209711A (fr) |
| CA (1) | CA2448634A1 (fr) |
| CO (1) | CO5540342A2 (fr) |
| CZ (1) | CZ20033450A3 (fr) |
| HK (1) | HK1069385A1 (fr) |
| HU (1) | HUP0401862A3 (fr) |
| IL (1) | IL159085A0 (fr) |
| MX (1) | MXPA03010811A (fr) |
| NO (1) | NO326688B1 (fr) |
| NZ (1) | NZ530358A (fr) |
| PL (1) | PL367639A1 (fr) |
| RU (1) | RU2299197C2 (fr) |
| TW (1) | TWI297008B (fr) |
| WO (1) | WO2002096880A1 (fr) |
| YU (1) | YU94003A (fr) |
| ZA (1) | ZA200309757B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002308891B2 (en) | 2001-05-29 | 2007-09-06 | Kyoto Pharmaceutical Industries, Ltd. | Novel heterocyclic derivatives and medicinal use thereof |
| US7816385B2 (en) * | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
| WO2004106542A1 (fr) * | 2003-05-29 | 2004-12-09 | Sankyo Company, Limited | Compose resistant a l'insuline et methode de criblage de celui-ci |
| TWI359810B (en) | 2004-11-04 | 2012-03-11 | Mitsubishi Tanabe Pharma Corp | Carboxylic acid derivative containing thiazole rin |
| US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
| WO2007058504A1 (fr) * | 2005-11-21 | 2007-05-24 | Lg Life Sciences, Ltd. | Nouveaux composes utilises comme agonistes des ppar gamma et des ppar alpha, procede de preparation afferent et composition pharmaceutique les renfermant |
| WO2012033195A1 (fr) * | 2010-09-10 | 2012-03-15 | 京都薬品工業株式会社 | Composé hétérocyclique |
| CN102807526B (zh) * | 2011-06-21 | 2015-12-02 | 寿光富康制药有限公司 | 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用 |
| WO2020013116A1 (fr) * | 2018-07-10 | 2020-01-16 | 京都薬品工業株式会社 | Inhibiteur de ptp-1b et son utilisation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6051189A (ja) | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| AR240698A1 (es) | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| SG59988A1 (en) | 1987-09-04 | 1999-02-22 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| US5246943A (en) | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| IL121202A (en) | 1996-07-01 | 2001-08-26 | Lilly Co Eli | Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof |
| IL121203A (en) | 1996-07-01 | 2001-04-30 | Lilly Co Eli | 1, 2, 3, 4-tetrahydroisoquinidines, process for their preparation and pharmaceutical compositions containing the same for treating hyperglycemia and hyperlipidemia |
| GB9817118D0 (en) | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| RU2256661C2 (ru) * | 1999-12-03 | 2005-07-20 | Киото Фармасьютикал Индастриз, Лтд. | Производные тетрагидроизохинолина и их соли и фармацевтическая композиция на их основе |
| US20020037897A1 (en) | 2000-08-07 | 2002-03-28 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| AU2002308891B2 (en) * | 2001-05-29 | 2007-09-06 | Kyoto Pharmaceutical Industries, Ltd. | Novel heterocyclic derivatives and medicinal use thereof |
-
2002
- 2002-05-27 EP EP02774070A patent/EP1403253A4/fr not_active Withdrawn
- 2002-05-27 CN CNB028109643A patent/CN1242994C/zh not_active Expired - Fee Related
- 2002-05-27 IL IL15908502A patent/IL159085A0/xx unknown
- 2002-05-27 CZ CZ20033450A patent/CZ20033450A3/cs unknown
- 2002-05-27 MX MXPA03010811A patent/MXPA03010811A/es active IP Right Grant
- 2002-05-27 JP JP2003500060A patent/JP4279136B2/ja not_active Expired - Fee Related
- 2002-05-27 KR KR10-2003-7015611A patent/KR20040030647A/ko not_active IP Right Cessation
- 2002-05-27 RU RU2003137574/04A patent/RU2299197C2/ru not_active IP Right Cessation
- 2002-05-27 ZA ZA200309757A patent/ZA200309757B/en unknown
- 2002-05-27 PL PL02367639A patent/PL367639A1/xx unknown
- 2002-05-27 KR KR1020087023698A patent/KR100898358B1/ko not_active IP Right Cessation
- 2002-05-27 NZ NZ530358A patent/NZ530358A/en unknown
- 2002-05-27 CA CA002448634A patent/CA2448634A1/fr not_active Abandoned
- 2002-05-27 WO PCT/JP2002/005097 patent/WO2002096880A1/fr active Application Filing
- 2002-05-27 YU YU94003A patent/YU94003A/sh unknown
- 2002-05-27 AU AU2002308889A patent/AU2002308889B2/en not_active Ceased
- 2002-05-27 BR BR0209711-7A patent/BR0209711A/pt not_active IP Right Cessation
- 2002-05-27 HU HU0401862A patent/HUP0401862A3/hu unknown
- 2002-05-27 US US10/478,862 patent/US7557123B2/en not_active Expired - Fee Related
- 2002-05-28 TW TW091111315A patent/TWI297008B/zh active
- 2002-05-29 AR ARP020102002A patent/AR036036A1/es unknown
-
2003
- 2003-11-28 NO NO20035331A patent/NO326688B1/no not_active IP Right Cessation
- 2003-12-29 CO CO03112806A patent/CO5540342A2/es not_active Application Discontinuation
-
2005
- 2005-03-02 HK HK05101815A patent/HK1069385A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080093076A (ko) | 2008-10-17 |
| CZ20033450A3 (cs) | 2004-05-12 |
| KR100898358B1 (ko) | 2009-05-20 |
| CO5540342A2 (es) | 2005-07-29 |
| CA2448634A1 (fr) | 2002-12-05 |
| RU2299197C2 (ru) | 2007-05-20 |
| HUP0401862A3 (en) | 2009-03-30 |
| MXPA03010811A (es) | 2004-02-27 |
| EP1403253A1 (fr) | 2004-03-31 |
| AR036036A1 (es) | 2004-08-04 |
| KR20040030647A (ko) | 2004-04-09 |
| CN1527819A (zh) | 2004-09-08 |
| AU2002308889B2 (en) | 2007-09-06 |
| BR0209711A (pt) | 2004-11-03 |
| RU2003137574A (ru) | 2005-05-20 |
| HK1069385A1 (en) | 2005-05-20 |
| HUP0401862A2 (hu) | 2004-12-28 |
| WO2002096880A1 (fr) | 2002-12-05 |
| TWI297008B (en) | 2008-05-21 |
| PL367639A1 (en) | 2005-03-07 |
| EP1403253A4 (fr) | 2005-03-30 |
| YU94003A (sh) | 2006-08-17 |
| NO20035331D0 (no) | 2003-11-28 |
| JPWO2002096880A1 (ja) | 2004-09-09 |
| CN1242994C (zh) | 2006-02-22 |
| NO326688B1 (no) | 2009-01-26 |
| JP4279136B2 (ja) | 2009-06-17 |
| ZA200309757B (en) | 2004-12-22 |
| US7557123B2 (en) | 2009-07-07 |
| US20040220215A1 (en) | 2004-11-04 |
| NZ530358A (en) | 2005-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157131A0 (en) | Nitrogen containing heterocyclic derivatives and pharmaceutical compositions containing the same | |
| IL161616A0 (en) | Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| IL158044A0 (en) | Cyclopropylindole derivatives and pharmaceutical compositions containing the same | |
| IL158300A0 (en) | Bisarylimidazol derivatives and pharmaceutical compositions containing the same | |
| IL162548A0 (en) | 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same | |
| IL166482A0 (en) | Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same | |
| IL158041A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| IL158523A0 (en) | Epothilone derivatives and pharmaceutical compositions containing the same | |
| IL157029A0 (en) | Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same | |
| IL158076A0 (en) | Benzamidine derivatives and pharmaceutical compositions containing the same | |
| IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
| HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
| IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
| IL162547A0 (en) | Fused heterocyclic succinimide derivatives and pharmaceutical compositions containing the same | |
| IL164455A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL164209A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL166620A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
| IL156031A0 (en) | Fused heterocyclic derivatives and pharmaceutical compositions containing the same | |
| IL156812A0 (en) | Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same | |
| IL148517A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL150077A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL173602A0 (en) | Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same | |
| IL173627A0 (en) | 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same | |
| IL159765A0 (en) | Aryl substituted thiazolidinone derivatives and pharmaceutical compositions containing the same | |
| IL163117A (en) | Indazole derivatives and pharmaceutical compositions containing the same |